In this episode, we explore aging, health span, and lifespan with leading expert, Professor Richard Faragher. We discuss why only 18% of people age well, what sets them apart, and practical strategies to improve healthy aging. The conversation covers emerging drug therapies—like metformin and rapamycin—that could slow aging, along with the economic challenges of developing and accessing these treatments. We also look ahead at the future of aging and the importance of personal health choices and continued research. Disclaimer: The information discussed in this podcast is for informational and educational purposes only. It is not intended to be medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making any changes to your health regimen, medications, or lifestyle. The views expressed are those of the guest and host and do not substitute for professional medical guidance.
In this episode, Jesse speaks with Professor Richard Faragher, one of the UK’s leading researchers on the biology of aging. They dive deep into why only 18% of people age well, what it means to age badly, and how emerging science is changing our understanding of aging itself.
Topics include:
Guest Bio: Dr. Richard Faragher is a professor of biogerontology at the University of Brighton. His research focuses on cellular senescence and the mechanisms of aging, and he’s a leading advocate for translating aging science into real-world interventions.
📺Watch the full pod on YouTube 📺https://youtu.be/x6Nru2NkFEM